期刊論文1. | 董安丹(20020300)。美國專利法上非顯著性之判斷--化學發明非顯著性之研究。智慧財產權月刊,39,36-72。 延伸查詢 |
2. | Blodgett, Gerry Alan(1981)。Relative Significance: A Concept in Chemical Structural Obviousness Cases。J. Pat. Off. Soc'y.,63,70。 |
3. | Portman, Robert M.(1996)。Legislative Restriction on Removes Medical and Surgical Procedure Patents Impediment to Medical Progress。U. Balt. Intell. Prop. J.,4,99。 |
4. | Ho, Cynthia M.(2000)。Patents, Patients, and Public Policy: An Incomplete. Intersection at 35 U.S.C. 287 (c)。U. C. Davis. Rev.,33,601-635。 |
5. | Klopscch, Geraldc(1982)。The Patentability of Pharmaceuticals According to the European Patent Convention (EPC)。IIC,13(4),458。 |
6. | Stieger, Werner(1982)。Article 54(5) of the Munich Patent Convention : An Exception for Pharmaceuticals。ICC,13,139。 |
7. | Utermann, Jasper(1986)。Purpose-Bound Process Claim for Pharmaceuticals-Two Solutions for the Second Indication。IIC,17,44。 |
8. | Benyamini, Amiram(1993)。Patent Infringement in the European Community。IIC,13,92-93。 |
9. | Perron, Jean M.(1985)。Patentability of a Second Indication of a Pharmaceutical in Europe。Idea--The Journal of Law and Technology,26,15。 |
10. | Marquis, Harold L.(1981)。Economic Analysis of the Patentability of Chemical Compounds。J. P. O. S.,63,3。 |
11. | Konkol, Chris P.(1990)。A Critique of the Concept of Relative Significance in Determining Obviousness。Idea--The Journal of Law and Technology,31,228。 |
12. | (1974)。Standards of Obviousness and the Patentability of Chemical Compounds。Harvard Law Review,87,618。 |
13. | 董安丹(20020400)。美國專利法上非顯著性之判斷--化學發明非顯著性之研究。智慧財產權月刊,40,33-54。 延伸查詢 |
14. | 董安丹(19990700)。美國專利法上之非顯著性:歷史發展及GRAHAM原則。智慧財產權月刊,7,頁80-87。 延伸查詢 |
15. | 董安丹(19990900)。美國專利法上之非顯著性:歷史發展及GRAHAM原則。智慧財產權月刊,9,頁66-74。 延伸查詢 |
16. | 董安丹(19991200)。美國專利法上之非顯著性:法律上之判斷標準。智慧財產權月刊,12,頁71-81。 延伸查詢 |
17. | 董安丹(19991000)。美國專利法上之非顯著性:法律上之判斷標準。智慧財產權月刊,10,頁69-82。 延伸查詢 |
18. | 董安丹(19991100)。美國專利法上之非顯著性:法律上之判斷標準。智慧財產權月刊,11,頁12-21。 延伸查詢 |
19. | Moufang, Rainer(1993)。Methods of Medical Treatment Under Patent Law。IIC,24(1),18-49。 |